TrialThe Journal of clinical endocrinology and metabolism2010

Piragliatin (RO4389620), a novel glucokinase activator, lowers plasma glucose both in the postabsorptive state and after a glucose challenge in patients with type 2 diabetes mellitus: a mechanistic study.

Riccardo C Bonadonna et al.PubMed ↗Publisher ↗

No numbers read from the abstract.